Mycophenolate mofetil as acute graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation in a murine model.

被引：0
|
作者：
Huang, H [1 ]
Zheng, WY [1 ]
Lin, MF [1 ]
Fu, JY [1 ]
Zhang, RH [1 ]
机构：
[1] Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Hangzhou 310027, Peoples R China
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5061
引用
收藏
页码：325B / 325B
页数：1
相关论文
共 50 条
  • [1] Administration of mycophenolate mofetil in a murine model of acute graft-versus-host disease after bone marrow transplantation
    vanLeeuwen, L
    Guiffre, AK
    Sewell, WA
    Vos, BJ
    Rainer, S
    Atkinson, K
    TRANSPLANTATION, 1997, 64 (08) : 1097 - 1101
  • [2] Acute Renal Graft-Versus-Host Disease in a Murine Model of Allogeneic Bone Marrow Transplantation
    Schmid, Peter M.
    Bouazzaoui, Abdellatif
    Schmid, Karin
    Birner, Christoph
    Schach, Christian
    Maier, Lars S.
    Holler, Ernst
    Endemann, Dierk H.
    CELL TRANSPLANTATION, 2017, 26 (08) : 1428 - 1440
  • [3] PHARMACOLOGICAL PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    SCHWINGHAMMER, TL
    BLOOM, EJ
    CLINICAL PHARMACY, 1993, 12 (10): : 736 - 761
  • [4] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    TRANSPLANTATION, 1999, 67 (04) : 499 - 504
  • [5] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    I Haentzschel
    J Freiberg-Richter
    U Platzbecker
    A Kiani
    J Schetelig
    T Illmer
    G Ehninger
    E Schleyer
    M Bornhäuser
    Bone Marrow Transplantation, 2008, 42 : 113 - 120
  • [6] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Haentzschel, I.
    Freiberg-Richter, J.
    Platzbecker, U.
    Kiani, A.
    Schetelig, J.
    Illmer, T.
    Ehninger, G.
    Schleyer, E.
    Bornhaeuser, M.
    BONE MARROW TRANSPLANTATION, 2008, 42 (02) : 113 - 120
  • [7] Mycophenolate mofetil, cyclosporine and methotrexate as acute graft versus host disease prophylaxis after matched unrelated donor allogeneic bone marrow transplantation.
    Huang, H
    Lin, MF
    Lee, ZD
    Meng, HT
    Qian, WB
    Yan, LX
    Cai, Z
    BLOOD, 2000, 96 (11) : 361B - 361B
  • [8] ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PERREAULT, C
    GYGER, M
    BOILEAU, J
    BONNY, Y
    COUSINEAU, S
    LACOMBE, M
    LAVALLEE, R
    TAWIL, E
    DANGELO, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 129 (09) : 969 - 974
  • [9] Targeting mycophenolate mofetil for graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation.
    Freiberg-Richter, Jens
    Hantzschel, Ingmar
    Jenke, Andreas
    Lorenz, Petra
    Ehninger, Gerhard
    Bornhaeuser, Martin
    BLOOD, 2006, 108 (11) : 227A - 227A
  • [10] Prophylaxis of acute hepatic graft-versus-host disease with ursodeoxycholic acid in allogeneic bone marrow transplantation
    Iwata, N
    Nakamura, Y
    Masui, H
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1997, 26 (04) : 1091 - 1091
12345